Company
Headquarters: Barcelona, Spain
Employees: 1,321
CEO: Mr. Antonio Zabalza Marti
€361.2 Million
EUR as of July 1, 2024
US$387.9 Million
Company | Market Cap (USD) |
---|---|
Air Liquide SA | $101.18 B |
Shin-Etsu Chemical Co Ltd | $79.85 B |
Saudi Basic Industries Corp | $59.17 B |
Air Products and Chemicals, Inc. | $56.17 B |
BASF SE | $43.57 B |
Company | Market Cap (USD) |
---|---|
Linde | $208.12 B |
BHP | $151.21 B |
Rio Tinto | $110.09 B |
Air Liquide SA | $101.18 B |
Southern Copper Corporation | $90.64 B |
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three divisions: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The Chlorine Derivatives division produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, vinyl chloride monomer and polychloride, and trichloroisocyanuric acid. Its products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; produce compound feed and in cooling equipment; and others. The Intermediate Chemicals division provides formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing resins, paints, varnishes, sockets and switches, tableware, health and packaging items, particles, and decorative laminated and plywood boards, as well as for use in the textile tanning industry. The Pharmaceuticals division engages in the manufacturing of raw materials and intermediate pharmaceutical products of antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal products. Its products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company also exports its products. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Ercros, SA has the following listings and related stock indices.
Stock: BME: ECR wb_incandescent
Stock: FSX: CRS1 wb_incandescent